Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

ENT Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11096 Neoplasms 8875 Carcinoma, Non-Small-Cell Lung 5754 Prostatic Neoplasms 5339 Colorectal Neoplasms 4995 Lung Neoplasms 4257 Pancreatic Neoplasms 3026 Multiple Myeloma 3023 Neoplasm Metastasis 2980 Leukemia, Myeloid, Acute 2961 Carcinoma, Hepatocellular 2762 Ovarian Neoplasms 2687 Melanoma 2657 Stomach Neoplasms 2593 Lymphoma 2528 Head and Neck Neoplasms 2186 Recurrence 2150 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2096 Leukemia 2020 Brain Neoplasms 1988 Colonic Neoplasms 1949 Lymphoma, Non-Hodgkin 1913 Rectal Neoplasms 1857 Uterine Cervical Neoplasms 1826 Glioblastoma 1710 Leukemia, Lymphocytic, Chronic, B-Cell 1681 Carcinoma, Renal Cell 1613 Squamous Cell Carcinoma of Head and Neck 1570 Lymphoma, Follicular 1539 Esophageal Neoplasms 1522

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02246244 2016-06-10

TADDOR

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

ENT Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡